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Abstract
Background: Drug resistance determination for Plasmodium falciparum infections are important to determining the 
type of treatment to be given. Besides in vivo experiments, molecular methods, such as sequencing and PCR, are now 
increasingly being used. Here a cheaper alternative to sequencing or the use of multiplex 5'nuclease PCR assay for 
detection and differentiation of drug resistance haplotypes for chloroquine and atovaquone using polymerase chain 
reaction-high resolution melt (PCR-HRM) is reported.
Methods: Separate PCR-HRM assays were designed for the detection and differentiation of chloroquine and 
atovaquone drug resistance haplotypes in P. falciparum. PCR was conducted on a thermal cycler and melt curves 
generated using a LightScanner. These were tested against reference strains of P. falciparum from MR4 as well as 53 
local isolates.
Results: The PCR-HRM assays are able to detect and differentiate between the various haplotypes consistently. These 
assays can also be used to detect new variants.
Conclusions: PCR-HRM is an inexpensive option for the determination of drug resistance profile in P. falciparum and 
will see increasing use as an alternative to sequencing and 5'nuclease PCR assays in reference laboratories or once PCR 
systems that are able to conduct HRM become commonplace.
Background
The molecular basis of chloroquine resistance (CQR) in
Plasmodium falciparum is still relatively unclear, and the
association of point mutations in different genes with
CQR has been largely studied in the last decade. In 2000,
the pfcrt gene was identified, which appears to play a cru-
cial role in CQR. A lysine to threonine change at position
76 (K76T), which was subsequently found in every in
vitro CQR parasite from around the world, was identified
a s  a n  i m p o r t a n t  m u t a t i o n  a s s o c i a t e d  w i t h  C Q R  [ 1 ] .
Although this mutation is not the sole requirement for
determining of CQR, the absence of the K76T mutation is
highly predictive of CQ sensitivity in vitro and CQ effi-
cacy in vivo [2].
Similarly, the molecular basis of atovaquone resistance
in P. falciparum has been suggested to be due to muta-
tions in the cytochrome bc1 gene of the parasite mito-
chondrial genome, which prevents binding of atovaquone
to the cytochrome [3]. In particular, mutations at codon
268 are associated with atovaquone/proguanil treatment
failure  in vivo and can be used as possible resistance
markers. Both the amino acid changes, Y268N and
Y268S, result in extremely high increase in resistance lev-
els [4]. There are also recent reports of Y268C mutants
that are also highly resistant to atovaquone [5].
One of the most common methods for single nucle-
otide polymorphism (SNP) detection is the conduct of a
polymerase chain reaction (PCR) flanking the mutation
site, followed by sequencing for confirmation [6]. This
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process is however both laborious and expensive. Follow-
ing the development of real-time PCR and relevant fluo-
rescence detection systems, SNP detection became
possible using fluorescent probe chemistries, such as the
5'nuclease PCR assay and fluorescent resonance energy
transfer (FRET) PCR. These assays confer specificity
while eliminating the need for confirmation via sequenc-
ing. Subsequently, PCR assays for the detection of chloro-
quine resistance based on these technologies were
developed and widely used [7-9]. However, the use of flu-
orescent probes is limited to single SNP detection per
probe and prior knowledge of the SNP location to design
the detection probes. Thus, this method is relatively
expensive especially in a multiplex PCR where several dif-
ferent fluorescent probes are required. In addition, there
may be more SNPs at a particular locus than combination
fluorescent probes that can be utilized. Hence, high reso-
lution melting (HRM) analysis offers potential as a solu-
tion and here a PCR-HRM method for distinguishing
between wild type and drug-resistant P. falciparum
strains in a single reaction without the need for multiple
fluorescent probes is presented.
The utility of HRM analysis for detection of point
mutations in P. falciparum genes associated with drug
resistance has been demonstrated earlier [10]. The tech-
nique employed, however, is heavily reliant on the resolu-
tion power of the equipment as differences in melting
temperature (Tm) between wild-type and mutant-type
isolates are less than 2°C. Furthermore, as the size of the
amplicon increases, the ability to detect small Tm differ-
ence decreases, thereby imposing a restriction on PCR
primer design. Here, asymmetric PCRs were developed
free from amplicon size restriction as the haplotype dis-
crimination depends on a short (20 - 35 nucleotides),
unlabeled 3'-blocked probe and LC Green Plus ® fluores-
cent dye. The assay is based on differences in melting
temperature between perfect matches and mismatches
under the probes and has been shown to be useful for
SNP genotyping in genetic studies [11].
Methods
Materials
DNA from reference strains of P. falciparum (harbouring
the known chloroquine resistance profiles) were provided
by Malaria Research and Reference Reagent Resource
Center (MR4) USA. These include MRA-152G, MRA-
155G, MRA-156G, MRA-175G, MRA-202G and MRA-
387G. DNA from these strains were used at a concentra-
tion of 1 pg/μl. Synthetic constructs were made for the
atovaquone-resistant profile types Y268N and Y268S and
were used at a concentration of 1 fmol/μl. A P. falciparum
blood sample with atovaquone-resistant profile Y268C
was obtained from Dr Colin Sutherland, London School
of Hygiene and Tropical Medicine, UK. 53 other isolates
of P. falciparum used in this study were part of a collec-
tion from DSO National Laboratories which were previ-
ously checked via PCR for mono-infection.
DNA extraction
DNA was extracted from P. falciparum positive blood
samples (parasitaemia greater than 0.05%) using the
QIAamp DNA Mini Kit (Qiagen Inc). 200 μl of blood
sample was used for extraction and DNA eluted in 100 μl
of elution buffer.
PCR-HRM for the detection of chloroquine resistance
Primers used were previously described [1] and probes
were designed using Primer 3 software [12]. The PCR was
set up in a final volume of 10 μl containing 1 μl of DNA,
75 nM of CRTD1 primer (5'-TGTGCTCATGTGTT-
TAAACTT-3'), 375 nM of CRTD2 primer (5'-CAAAAC-
TATAGTTACCAATTTTG-3'), 500 nM of CRTWT
probe (5'-TGTATGTGTAATGAATAAAATTTTTGC-
phosphate-3'), 375 μM dNTP mix, 1× reaction buffer, 1×
LC Green Plus (Idaho Technology Inc., USA), 6.875 mM
MgCl2 and 0.5 U of Platinum Taq polymerase (Invitrogen
Corp). After overlaying the PCR mix with 20 μl mineral
oil, the following conditions were used: 95°C for 6 min; 60
cycles of 95°C for 15 s and 55°C for 1 min; followed by
94°C for 30 s and 25°C for 30 s for heteroduplex forma-
tion and 15°C for storage. This is followed by melt curve
analysis on the LightScanner (Idaho Technology Inc.,
USA).
Real-time PCR for the detection of chloroquine resistance
The chloroquine resistance haplotypes for all P. falci-
parum isolates were determined using the multiplex real-
time PCR assay developed by Sutherland et al [8].
PCR-HRM for the detection of atovaquone resistance
Primers and probes were designed using Primer 3 soft-
ware. The PCR was set up in a final volume of 10 μl con-
taining 1 μl of DNA, 50 nM of cytbF primer (5'-
CACATCCTGATAATGCTATCG-3'), 250 nM of cytbR
primer (5'-AGCTGGTTTACTTGGAACAG-3'), 500 nM
of WT probe (5'-GGTACTTTCTACCATTTTATG-
CAATG-phosphate-3'), 100 μM dNTP mix, 1× reaction
buffer, 1× LC Green Plus, 1.5 mM MgCl2 and 0.5 U of
Platinum Taq polymerase. After overlaying the PCR mix
with 20 μl mineral oil, the following conditions were used:
95°C for 6 min; 60 cycles of 94°C for 10 s, 55°C for 10 s
and 72°C for 10 s; 72°C for 3 min, followed by 94°C for 30
s and 25°C for 30 s for heteroduplex formation and 15°C
for storage. This is followed by melt curve analysis on the
LightScanner (Idaho Technology Inc., USA).
PCR-RFLP for the detection of atovaquone resistance
The atovaquone resistance haplotypes for all P. falci-
parum  isolates were determined using the PCR-RFLP
method developed by Schwöbel et al [4].Gan and Loh Malaria Journal 2010, 9:134
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Sensitivity of HRM assay in single and mixed strains 
reactions
In order to determine HRM assay sensitivity, serial dilu-
tions of DNA (10-1 to 10-5 ng/μl) were tested. The pfcrt
HRM assay was carried out on three different reference
strains, MRA-102G (CVMNK haplotype), MRA-152G
(SVMNT haplotype) and MRA-150G (CVIET haplotype)
in duplicates. The same procedure was also performed on
the atovaquone HRM assay but only with MRA-102G
wild type reference strain.
The ability of the method to detect a minority haplo-
type in a mixture of wild- and mutant-type pfcrt alleles
was also assessed. DNA concentration of both MRA-
102G (CVMNK) and MRA-150G (CVIET) reference
strains were adjusted to 0.1 ng/μl and combined to have
the following CVMNK/CVIET ratio: 10:90, 30:70, 50:50,
70:30, 90:10.
DNA Sequencing
Sanger's dideoxy sequencing was carried out on Exo-SAP
purified PCR products using Big Dye Terminator v3.1
chemistry and electrophorezed on the Applied Biosystem
3730 Genetic Analyzer (Applied Biosystems, USA).
Results
PCR-HRM for the detection of chloroquine resistance
The results show that the wild type haplotype (CVMNK)
could be easily differentiated from the mutant resistant
haplotypes (CVIET and SVMNT) since the difference in
Tm is more than 7°C (Figure 1). The difference between
CVIET and SVMNT haplotypes is only 2°C but this has
been tested to be reproducible and consistent. The
method had a detection threshold of 10-4 ng/μl for the
wild type (CVMNK) (Figure 2) and SVMNT haplotype,
while the detection threshold for CVIET haplotype was
higher at 10-3 ng/μl. A similar trend for sensitivity was
observed when detecting minority haplotype in mixed-
alleles samples; only 10% of wild-type haplotype is
required to be present in a mixture in order to be
detected by the HRM assay, whereas at least 30% of the
CVIET haplotype is required in a mixture before being
detected due to the assay's lower sensitivity for the
CVIET haplotype (Figure 3). The developed method was
tested against 53 P. falciparum strains that have previ-
ously been typed using a real-time PCR method devel-
oped by Sutherland et al [8]. Of the 53 isolates tested, five
had the CVMNK haplotype, 18 had the CVIET haplotype
and the remaining 30 isolates had the SVMNT haplotype.
96.2% concordance was achieved between the two meth-
ods because two of the 30 SVMNT isolates gave a Tm
peak that was 1°C higher than that of the CVIET haplo-
type (Figure 4). Although real-time PCR typed these two
strains as SVMNT haplotypes, sequencing of the PCR
product confirmed that they are of the SVMNT haplo-
type but with an additional "A" to "G" point mutation in
codon 71 just upstream of codon 72 (Figure 5). Whether
this mutation has an effect on chloroquine sensitivity of
these two isolates was not explored further in this study.
PCR-HRM for the detection of atovaquone resistance
The results show that the wild type haplotype (Y268Y)
could also be easily differentiated from the mutant resis-
tant haplotypes (Y268N, Y268S and Y268C) since the dif-
f e r e n c e  i n  T m  i s  m o r e  t h a n  6 ° C  ( F i g u r e  6 ) .  T h e  T m
Figure 1 High resolution melt profile of the 3 pfcrt haplotypes.
Figure 2 High resolution melt profile for the pfcrt sensitivity as-
say using MRA-102G.
Figure 3 High resolution melt profile of different proportions of 
CVMNK:CVIET mixes to assess the detection threshold of the mi-
nority haplotype.Gan and Loh Malaria Journal 2010, 9:134
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differences between the mutant haplotypes however are
much smaller at between 1 to 1.5°C but have also shown
to be reproducible and consistent. The detection thresh-
old for wild type haplotype is higher compared to that for
the pfcrt PCR-HRM at 10-5 ng/ul (Figure 7). Sensitivity for
other haplotypes was not tested due to lack of isolates for
testing. The same 53 P. falciparum strains were tested and
compared against their haplotypes determined using
PCR-RFLP according to the method developed by
Schwobel et al [4]. In this case, all 53 isolates had the wild
type haplotype (Y268Y). 100% concordance was achieved
between the two techniques.
Discussion
The PCR-HRM technique developed here is relatively
inexpensive compared to the use of multiple fluorescent
probes or sequencing [13]. It provides a quick way to dif-
ferentiate between drug-resistant strains and drug-sensi-
tive strains using only a single unlabeled probe in an
asymmetric PCR followed by a melt curve which is easily
done without further chemistries. This technique is an
improvement on the assay developed by Andriant-
soanirina et al [10], as the use of the unlabeled probe
allows for very clear distinction between wild-type and
mutant type strains. Difficulties may be encountered in
determining the exact resistant haplotype due to the
small difference in Tm if PCR conditions and reagents
used are not optimal or there is a lack of controls for each
haplotype in the run. However, determination of drug
resistance on a qualitative scale (i.e. sensitive or drug
resistant) is relatively easy with this assay due to the
larger Tm differences between wild type (sensitive) hap-
lotype and resistant haplotypes.
Its ease of use is especially observed for detection of
atovaquone resistance where alternatives currently avail-
able are sequencing and PCR-RFLP [4]. Development of a
multiplex 5'nuclease PCR assay to differentiate between
the four haplotypes is not impossible but will likely
require the use of multiple Lock-nucleic acid (LNA) or
Minor grove binding (MGB) fluorescent-tagged probes
which adds to the cost of the assay.
In addition, the use of HRM allows for the detection of
new variants from the wild type, which could potentially
be drug-resistant as well. It is predicted that the PCR -
HRM method developed for pfcrt will be useful for the
detection and differentiation of CVMNT, CVIKT and
SVIET haplotypes discovered in Papua New Guinea [14]
from wild type as well. This is further exemplified in the
detection of two P. falciparum strains harbouring a point
mutation just upstream of the variable region in pfcrt
Figure 6 High resolution melt profile of the 4 haplotypes for de-
tection of atovaquone resistance using the cytB protocol.
Figure 7 High resolution melt profile for the cytB sensitivity assay 
using MRA-102G.
Figure 4 High resolution melt profile of the 'unknown' haplotype 
with respect to the 3 common pfcrt haplotypes.
Figure 5 "Unknown" haplotype has a point mutation (A->G) in 
codon 71 just upstream of the SVMNT signature.Gan and Loh Malaria Journal 2010, 9:134
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gene and confirmed by sequencing. The importance of
this mutation is not known but it would have gone unno-
ticed if only the 5'nuclease PCR assay was used for detec-
tion purposes.
In this study , two systems were used in combination
(conventional thermal cycler and the LightScanner) to
generate the required result. There are now systems in
the market that can do PCR and HRM together such as
the Roche Lightcycler 480, Applied Biosystems ABI 7500
Fast PCR system as well as the Qiagen Rotor-Gene 6000
and it is expected that as such systems become more
commonplace, it will provide a better option for seamless
operation. However this needs to be tested to ensure that
the HRM is of sufficient resolution power and robust
enough to differentiate between mutant haplotypes con-
sistently.
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